Your browser doesn't support javascript.
loading
Metabolomics profiling of valproic acid-induced symptoms resembling autism spectrum disorders using 1H NMR spectral analysis in rat model.
Kim, Hyang Yeon; Lee, Yong-Jae; Kim, Sun Jae; Lee, Jung Dae; Kim, Suhkmann; Ko, Mee Jung; Kim, Ji-Woon; Shin, Chan Young; Kim, Kyu-Bong.
Afiliación
  • Kim HY; College of Pharmacy, Dankook University, Cheonan, Chungnam, Republic of Korea.
  • Lee YJ; Center for Human Risk Assessment, Dankook University, Cheonan, Chungnam Republic of Korea.
  • Kim SJ; College of Pharmacy, Dankook University, Cheonan, Chungnam, Republic of Korea.
  • Lee JD; College of Pharmacy, Dankook University, Cheonan, Chungnam, Republic of Korea.
  • Kim S; College of Pharmacy, Dankook University, Cheonan, Chungnam, Republic of Korea.
  • Ko MJ; Center for Human Risk Assessment, Dankook University, Cheonan, Chungnam Republic of Korea.
  • Kim JW; Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan Republic of Korea.
  • Shin CY; Department Of Neuroscience, School Of Medicine, Konkuk University, Seoul, Republic of Korea.
  • Kim KB; Department Of Neuroscience, School Of Medicine, Konkuk University, Seoul, Republic of Korea.
J Toxicol Environ Health A ; 85(1): 1-13, 2022 01 02.
Article en En | MEDLINE | ID: mdl-34445937
Prenatal exposure to valproic acid (VPA) has been implicated in the manifestation of autism spectrum disorder (ASD)-like behavioral and functional changes both in human and rodents including mice and rats. The objective of this study was to determine metabolomics profiling and biomarkers related to VPA-induced symptoms resembling ASD using proton nuclear magnetic resonance (1H-NMR) spectral data. VPA was administered to pregnant rats at gestation day 12.5 and effects measured subsequently in male 4-week-old offspring pups. The sociability of VPA-treated animals was significantly diminished and exhibited ASD-like behavior as evidenced by reduction of social adaptation disorder and lack of social interactions. To find biomarkers related to ASD, the following were collected prefrontal brain cortices, urine bladder and blood samples directly from heart puncture. In all samples, principal component analysis (PCA) and partial least-squares discriminant analysis (PLS-DA) displayed significant clustering pattern differences between control and treated groups. Valine, taurine, myo-inositol, 3-hydroxybutyrate and 1,3-dihydroxyacetone were significantly decreased in brain cortices in treated rats. Serum metabolites of glucose, creatine phosphate, lactate, glutamine and threonine were significantly increased in VPA-administered animals. Urinary metabolites of pimelate, 3-hydroxyisovalerate and valerate were significantly reduced in VPA-treated rat, whereas galactose and galactonate levels were elevated. Various metabolites were associated with mitochondrial dysfunction metabolism and central nervous system disorders. Data demonstrated that VPA-induced alterations in endogenous metabolites of serum, urine, and brain cortex which might prove useful as biomarkers for symptoms resembling ASD as a model of this disorder.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Valproico / Modelos Animales de Enfermedad / Trastorno del Espectro Autista Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Animals Idioma: En Revista: J Toxicol Environ Health A Asunto de la revista: SAUDE AMBIENTAL / TOXICOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Valproico / Modelos Animales de Enfermedad / Trastorno del Espectro Autista Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Animals Idioma: En Revista: J Toxicol Environ Health A Asunto de la revista: SAUDE AMBIENTAL / TOXICOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido